Shopping Cart 0
Cart Subtotal
USD 0

Vistin Pharma AS (VISTIN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Vistin Pharma AS (Vistin), a subsidiary of Vistin Pharma ASA is a healthcare company that produces and supplies active pharmaceutical ingredients and solid dosage forms. The company's products include opioids, an analgesics and antitussive; metformin, an API for the treatment of diabetes II; and pholcodine, an antitussive. It also provides branded and patented combinations products and plain generic and branded generic metformin tablets. Vistin Pharma offers contract manufacturing for granulate and solid dosage forms and offers customer service, technical services and logistics services. The company provides its products and services to international pharmaceutical companies. It operates through a network of distributors and agents located across Africa, Europe, Asia, and the Americas. The company's manufacturing facilities are located in Sannidal and Kragero, Norway. Vistin Pharma is headquartered in Oslo, Norway.

Vistin Pharma AS (VISTIN)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Vistin Pharma AS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Vistin Pharma AS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Vistin Pharma AS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Vistin Pharma AS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Vistin Pharma AS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Vistin Pharma AS, Pharmaceuticals & Healthcare, Deal Details 10

Equity Offering 10

Vistin Pharma Raises USD6.2 Million in Private Placement of Shares 10

Vistin Pharma Raises USD38.8 Million in Private Placement of Shares 12

Vistin Pharma Raises USD20 Million in Rights Offering of Shares 13

Asset Transactions 14

TPI Enterprises Acquires Opioids and CMO Business from Vistin Pharma 14

Acquisition 15

Geveran Trading Divests 5.17% Stake in Vistin Pharma 15

Vistin Pharma AS-Key Competitors 16

Vistin Pharma AS-Key Employees 17

Vistin Pharma AS-Locations And Subsidiaries 18

Head Office 18

Recent Developments 19

Strategy And Business Planning 19

Jan 30, 2018: Vistin Pharma ASA : Vistin Pharma to postpone the expansion of the metformin production capacity 19

Financial Announcements 20

Aug 30, 2018: Vistin Pharma announces 20 per cent revenue growth in second quarter 2018 20

Apr 26, 2018: Vistin Pharma : Delivers 22% revenue growth in first quarter 2018 21

Feb 27, 2018: Vistin Pharma : Fourth quarter 2017 results 22

Oct 27, 2017: Vistin Pharma: Third quarter 2017 results-strong growth, capacity expansion on track 23

Apr 26, 2017: Vistin Pharma: First quarter 2017 results 24

Feb 28, 2017: Vistin Pharma: Fourth quarter and preliminary 2016 results 25

Other Significant Developments 26

Aug 31, 2017: Vistin Pharma Second quarter 2017 results-continuing strong demand for metformin 26

Appendix 27

Methodology 27

About GlobalData 27

Contact Us 27

Disclaimer 27


List Of Figure

List of Figures

Vistin Pharma AS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Vistin Pharma AS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Vistin Pharma AS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Vistin Pharma AS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Vistin Pharma AS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Vistin Pharma AS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Vistin Pharma AS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Vistin Pharma AS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8


List Of Table

List of Tables

Vistin Pharma AS, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Vistin Pharma AS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Vistin Pharma AS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Vistin Pharma AS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Vistin Pharma AS, Deals By Therapy Area, 2012 to YTD 2018 8

Vistin Pharma AS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Vistin Pharma Raises USD6.2 Million in Private Placement of Shares 10

Vistin Pharma Raises USD38.8 Million in Private Placement of Shares 12

Vistin Pharma Raises USD20 Million in Rights Offering of Shares 13

TPI Enterprises Acquires Opioids and CMO Business from Vistin Pharma 14

Geveran Trading Divests 5.17% Stake in Vistin Pharma 15

Vistin Pharma AS, Key Competitors 16

Vistin Pharma AS, Key Employees 17

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Vistin Pharma AS, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.